Delisting riskPopularity #4,364
JSPR · NASDAQ · Biotechnology

Jasper Therapeutics (JSPR)

Develops complement inhibitors and targeted antibodies for immunological disorders.

$0.6396
vs last close+0.04 (+6.12%)